Effect of polyisobutylcyanoacrylate nanoparticles and Lipofectin® loaded with oligonucleotides on cell viability and PKCα neosynthesis in HepG2 cells

Biochimie

Volumn 80, Issue 12, 1998, Pages 969-976

  Lambert, Gregory ^a   Fattal, Elias ^a   Brehier, Arlette ^b   Feger, Jeanne ^b   Couvreur, Patrick ^a  

^a CNRS   (France)

^b INSERM   (France)

Author keywords

Antisense oligonucleotides; Cetyltrimethyl ammonium bromide; Nanoparticles; Polyalkylcyanoacrylate; Protein kinase C

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BUCRILATE; CETRIMIDE; DRUG CARRIER; LIPOFECTIN; NANOPARTICLE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYMER; PROTEIN KINASE C;

ADSORPTION; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING;

EID: 0032293435     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80002-9     Document Type: Article

References (20)

1. [1] De Mesmaeker A., Altmann K.H., Waldner A., Wendeborn S., Backbone modifications in oligonucleotides and peptide nucleic acid systems, Curr. Opin. Struct. Biol. 5 (1995) 343-355.
2. [2] Agrawal S., Jiang Z., Zhao Q., Shaw D., Cai Q., Roskey A., Channavajjala L., Saxinger C., Zhang R., Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies, Proc. Natl. Acad. Sci. USA 94 (1997) 2620-2625.
3. [3] Krieg A.M., Stein C.A., Phosphorothioate oligodeoxynucleotides: antisense or anti-protein? [editorial], Antisense Res. Dev. 5 (1995) 241.
4. [4] Black L.E., Farrelly J.G., Cavagnaro J.A., Ahn C.H., DeGeorge J.J., Taylor A.S., DeFelice A.F., Jordan A., Regulatory considerations for oligonucleotide drugs: updated recommendations for pharmacology and toxicology studies, Antisense Res. Dev. 4 (1994) 299-301.
5. [5] Hug H., Sarre T.F., Protein kinase C isoenzymes: divergence in signal transduction?, Biochem. J. 291 (1993) 329-343.
6. [6] Nishizuka Y., Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C, Science 258 (1992) 607-614.
7. [7] Dekker L.V., Parker P.J., Protein kinase C - a question of specificity, Trends Biochem. Sci. 19 (1994) 73-77.
8. [8] Makowske M., Ballester R., Cayre Y., Rosen O.M., Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid, J. Biol. Chem. 263 (1988) 3402-3410.
9. [9] Patrone M., Pessino A., Passalacqua M., Sparatore B., Melloni E., Pontremoli S., Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process, FEBS Lett. 344 (1994) 91-95.
10. [10] Ducher L., Croquet F., Gil S., Davy J., Feger J., Brehier A., Differential expression of five protein kinase C isoenzymes in FAO and HepG2 hepatoma cell lines compared with normal rat hepatocytes, Biochem. Biophys. Res. Commun. 217 (1995) 546-553.
11. [11] Courage C., Budworth J., Gescher A., Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation, Br. J. Cancer 71 (1995) 697-704.
12. [12] Dean N.M., McKay R., Condon T.P., Bennett C.F., Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters, J. Biol. Chem. 269 (1994) 16416-16424.
13. [13] Chavany C., Saison-Behmoaras T., LeDoan T., Puisieux F., Couvreur P., Helene C., Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake, Pharmacol. Res. 11 (1994) 1370-1378.
14. [14] Fattal E., Vauthier C., Aynie I., Nakada Y., Lambert G., Malvy C., Couvreur C., Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides, J. Control. Rel. 53 (1998) 137-143.
15. [15] Schwab G., Chavany C., Duroux I., Goubin G., Lebeau J., Helene C., Saison-Behmoaras T., Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice, Proc. Natl. Acad. Sci. USA 91 (1994) 10460-10464.
16. [16] Aynie I., Vauthier C., Foulquier M., Malvy C., Fattal E., Couvreur P., Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier, Anal. Biochem. 240 (1996) 202-209.
17. [17] Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P., Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties, J. Pharm. Pharmacol. 31 (1979) 331-332.
18. [18] Knowles B.B., Howe C.C., Aden D.P., Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science 209 (1980) 497-499.
19. [19] Denizot F., Lang R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J. Immunol. Methods 89 (1986) 271-277.
20. [20] Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.